# NeoVas Bioresorbable Coronary Scaffold Randomized Controlled Trial

> **NCT02305485** · NA · UNKNOWN · sponsor: **Lepu Medical Technology (Beijing) Co., Ltd.** · enrollment: 560 (estimated)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DEVICE:** NeoVas BCS
- **DEVICE:** XIENCE PRIME EECSS

## Key facts

- **NCT ID:** NCT02305485
- **Lead sponsor:** Lepu Medical Technology (Beijing) Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-11
- **Primary completion:** 2016-12
- **Final completion:** 2020-06
- **Target enrollment:** 560 (ESTIMATED)
- **Last updated:** 2016-12-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02305485

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02305485, "NeoVas Bioresorbable Coronary Scaffold Randomized Controlled Trial". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02305485. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*